Cetromed is a venture capital firm that identifies late-stage translational research projects in cutting-edge technologies and builds on accredited research, the early stages of which have already been funded by academical institutions including universities and medical schools. It acts as a bridge between academia and providers of venture capital and strategic finance, providing hands-on management expertise and investing or arranging seed capital for our projects. The firm is based in London, United Kingdom.